» Articles » PMID: 37605654

Growth Hormone Proteoformics Atlas Created to Promote Predictive, Preventive, and Personalized Approach in Overall Management of Pituitary Neuroendocrine Tumors

Overview
Journal EPMA J
Date 2023 Aug 22
PMID 37605654
Authors
Affiliations
Soon will be listed here.
Abstract

Human growth hormone (GH) is the indispensable hormone for the maintenance of normal physiological functions of the human body, including the growth, development, metabolism, and even immunoregulation. The GH is synthesized, secreted, and stored by somatotroph cells in adenohypophysis. Abnormal GH is associated with various GH-related diseases, such as acromegaly, dwarfism, diabetes, and cancer. Currently, some studies found there are dozens or even hundreds of GH proteoforms in tissue and serum as well as a series of GH-binding protein (GHBP) proteoforms and GH receptor (GHR) proteoforms were also identified. The structure-function relationship of protein hormone proteoforms is significantly important to reveal their overall physiological and pathophysiological mechanisms. We propose the use of proteoformics to study the relationship between every GH proteoform and different physiological/pathophysiological states to clarify the pathogenic mechanism of GH-related disease such as pituitary neuroendocrine tumor and conduct precise molecular classification to promote predictive preventive personalized medicine (PPPM / 3P medicine). This article reviews GH proteoformics in GH-related disease such as pituitary neuroendocrine tumor, which has the potential role to provide novel insight into pathogenic mechanism, discover novel therapeutic targets, identify effective GH proteoform biomarker for patient stratification, predictive diagnosis, and prognostic assessment, improve therapy method, and further accelerate the development of 3P medicine.

Citing Articles

Editorial: Biomolecular modifications in endocrine-related cancers, volume II.

Zhan X, Li N, Grech G Front Endocrinol (Lausanne). 2024; 15:1485789.

PMID: 39415795 PMC: 11479951. DOI: 10.3389/fendo.2024.1485789.


IGF-I and GH Genes polymorphism and their association with milk yields, composition and reproductive performance in Holstein-Friesian dairy cattle.

Saleh A, Hassan T, El-Hedainy D, El-Barbary A, Sharaby M, Hafez E BMC Vet Res. 2024; 20(1):341.

PMID: 39095829 PMC: 11295711. DOI: 10.1186/s12917-024-04188-4.

References
1.
Kiseljak-Vassiliades K, Carlson N, Borges M, Kleinschmidt-DeMasters B, Lillehei K, Kerr J . Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine. 2014; 49(1):231-41. PMC: 4331291. DOI: 10.1007/s12020-014-0383-y. View

2.
Godowski P, Leung D, Meacham L, Galgani J, Hellmiss R, KERET R . Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A. 1989; 86(20):8083-7. PMC: 298219. DOI: 10.1073/pnas.86.20.8083. View

3.
Velkeniers B, Dogusan Z, Naessens F, Hooghe R, Hooghe-Peters E . Prolactin, growth hormone and the immune system in humans. Cell Mol Life Sci. 1998; 54(10):1102-8. PMC: 11147331. DOI: 10.1007/s000180050239. View

4.
Li B, Wang X, Yang C, Wen S, Li J, Li N . Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches. EPMA J. 2021; 12(1):67-89. PMC: 7954920. DOI: 10.1007/s13167-021-00232-7. View

5.
Owerbach D, Rutter W, Martial J, Baxter J, Shows T . Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science. 1980; 209(4453):289-92. DOI: 10.1126/science.7384802. View